BrightSpring Health Services, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$3.55B
↑+91.0% +$1.69Bvs FY2024 (Q4)
Gross Profit
$413M
↑+313.0% +$313Mvs FY2024 (Q4)
Operating Income
$108M
Net Income
$50M
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $3.55B | $1.86B |
| COGS | $3.14B | $1.76B |
| Gross Profit | $413M | $100M |
| R&D | $0 | $0 |
| SG&A | $304M | $119M |
| D&A | $0 | $55M |
| Other OpEx | $0 | $0 |
| Operating Income | $108M | $0 |
| Interest Exp. | $39M | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $70M | $0 |
| Tax | $20M | $0 |
| Net Income | $50M | $0 |
QuarterCharts · SEC EDGAR data · BTSG · Comparing FY2025 (Q4) vs FY2024 (Q4)